Hyundai Bioscience Co. Ltd Free Cash Flow Generation Index
Hyundai Bioscience Co. Ltd free cash flow generation index. Hyundai Bioscience Co. Ltd (048410) has a Free Cash Flow Generation Index of -1.81x as of December 2024. Free cash flow of ₩-4.09 Billion represents -2% of operating cash flow (₩2.26 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hyundai Bioscience Co. Ltd (2008–2024)
Free cash flow generation index of Hyundai Bioscience Co. Ltd from 2008 to 2024. Historical FCF Generation Index trend for Hyundai Bioscience Co. Ltd across 8 annual periods. See financial agility of Hyundai Bioscience Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Hyundai Bioscience Co. Ltd Free Cash Flow Generation Index by Year (2008–2024)
Hyundai Bioscience Co. Ltd free cash flow generation index by year from 2008 to 2024. Year-by-year Free Cash Flow Generation Index for Hyundai Bioscience Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Hyundai Bioscience Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | ₩87.48 Million | ₩2.26 Billion | ₩2.17 Billion | ▲ +101.6% |
| 2020 | -2.36x | ₩-17.70 Billion | ₩7.50 Billion | ₩25.20 Billion | ▼ -433.3% |
| 2019 | -0.44x | ₩-4.06 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -118.3% |
| 2018 | 2.41x | ₩12.07 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -71.3% |
| 2015 | 8.41x | ₩734.93 Million | ₩87.36 Million | ₩647.57 Million | ▲ +398.9% |
| 2014 | 1.69x | ₩2.06 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +58.0% |
| 2011 | 1.07x | ₩4.24 Billion | ₩3.97 Billion | ₩267.78 Million | ▼ -22.5% |
| 2008 | 1.38x | ₩14.29 Billion | ₩10.37 Billion | ₩3.92 Billion | — |